Delivery Order SPE2DB22D1106-SPE2DB25FESS1

Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $48K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $17,382.55 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccines. The contract has an ultimate completion date of April 3, 2025 and was awarded on April 2, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a $41,394.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine product. The contract has a completion date of March 27, 2025 and was awarded on March 26, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a $46,815.50 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 10 mL vials of the TYPHIM VI 25 mcg/0.5 mL vaccine. The contract has an ultimate completion date of July 19, 2024. AmerisourceBergen is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. This delivery order is part of...
This is a $3,449.50 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine product. The delivery order has an ultimate completion date of May 20, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a $122,896.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, to support military and federal healthcare programs. The contract has an ultimate completion date of July 16, 2024 and was awarded on July 15, 2024. No set-aside designation was used for this open...
This is a $53,505.50 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit subsidiary company of AmerisourceBergen Corporation. The order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccines and is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceuticals and medical supplies to DLA Troop...
This is a $1,134.90 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with a performance period ending on June 11, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,589.87 contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has an ultimate completion date of June 17, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine product. The contract has a firm fixed price of $8,278.80 and a completion date of April 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a $46,466.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with a completion date of February 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FESS1
    Delivery Order

This is a $48,293.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccines. The contract has an ultimate completion date of June 11, 2025. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. This delivery order is not designated as a set-aside contract, indicating open competition.

Generated 9/14/25, 12:43 AM